[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:primary-sjogren-syndrome":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":21,"states":22},"Primary Sjogren Syndrome",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06979531","Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity",[11],"Phase 2","RECRUITING","2026-08-26T02:18:03.638950Z","2026-05-05T02:43:27.304700Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT06440525","A Study of RSLV-132 in Females With Sjögren's Disease",[11],"2026-08-26T02:17:55.355429Z","2026-05-05T02:43:27.061735Z",[],[]]